Wednesday, March 15, 2017

British Journal of Cancer - Table of Contents alert Volume 116 Issue 6

If you are unable to see the message below, click here to view.
British Journal of Cancer

All content now free to access including archives!

Nature Communications is an open access journal that publishes high-quality research from all areas of the natural sciences. Papers published by the journal represent important advances of significance to specialists within each subject area including the life sciences.

Visit the website to explore ALL the content available within your field >>


Volume 116, Issue 6 (697-840)
Published online 14 March 2017

In this issue
Clinical Studies
Translational Therapeutics
Molecular Diagnostics
Genetics & Genomics

Also new today
Advance online publication
Digital Edition
Sign up for e-alerts Follow BJC on Twitter Follow us on Twitter

Sign up for e-alerts
Recommend to your library
Web feed

Clinical Studies


Overall survival and clinical characteristics of BRCA mutation carriers with stage I/II pancreatic cancer

Talia Golan, Tal Sella, Eileen M O'Reilly, Matthew H G Katz, Ron Epelbaum, David P Kelsen, Ayelet Borgida, Hannah Maynard, Hedy Kindler, Eitan Friedmen, Milind Javle and Steven Gallinger

Br J Cancer 2017 116: 697-702; advance online publication, February 9, 2017; 10.1038/bjc.2017.19

Abstract | Full Text

Comparison of outcomes following a cytological or histological diagnosis of malignant mesothelioma

Sanjeevan Muruganandan, Helman Alfonso, Peter Franklin, Keith Shilkin, Amanda Segal, Nola Olsen, Alison Reid, Nick de Klerk, AW (Bill) Musk and Fraser Brims

Br J Cancer 2017 116: 703-708; advance online publication, February 14, 2017; 10.1038/bjc.2017.20

Abstract | Full Text

Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/ cetuximab in oesophageal cancer

T Crosby, C N Hurt, S Falk, S Gollins, J Staffurth, R Ray, J A Bridgewater, J I Geh, D Cunningham, J Blazeby, R Roy, T Maughan, G Griffiths and S Mukherjee

Br J Cancer 2017 116: 709-716; advance online publication, February 14, 2017; 10.1038/bjc.2017.21

Abstract | Full Text

Revisiting a longstanding clinical trial exclusion criterion: impact of prior cancer in early-stage lung cancer

Sandi L Pruitt, Andrew L Laccetti, Lei Xuan, Ethan A Halm and David E Gerber

Br J Cancer 2017 116: 717-725; advance online publication, February 14, 2017; 10.1038/bjc.2017.27

Abstract | Full Text

Translational Therapeutics


Correlation between PIK3CA mutations in cell-free DNA and everolimus efficacy in HR+, HER2 advanced breast cancer: results from BOLERO-2

Mary Ellen Moynahan, David Chen, Wei He, Patricia Sung, Aliaksandra Samoila, Daoqi You, Trusha Bhatt, Parul Patel, Francois Ringeisen, Gabriel N Hortobagyi, Jose Baselga and Sarat Chandarlapaty

Br J Cancer 2017 116: 726-730; advance online publication, February 9, 2017; 10.1038/bjc.2017.25

Abstract | Full Text

Prognostication and monitoring of mesothelioma using biomarkers: a systematic review

David T Arnold, Duneesha De Fonseka, Fergus W Hamilton, Najib M Rahman and Nick A Maskell

Br J Cancer 2017 116: 731-741; advance online publication, February 7, 2017; 10.1038/bjc.2017.22

Abstract | Full Text

MT4-MMP and EGFR expression levels are key biomarkers for breast cancer patient response to chemotherapy and erlotinib

Cassandre Yip, Pierre Foidart, Joan Somja, Alice Truong, Mehdi Lienard, Emilie Feyereisen, Hélène Schroeder, Stéphanie Gofflot, Anne-Françoise Donneau, Joëlle Collignon, Philippe Delvenne, Nor Eddine Sounni, Guy Jerusalem and Agnès Noël

Br J Cancer 2017 116: 742-751; advance online publication, February 14, 2017; 10.1038/bjc.2017.23

Abstract | Full Text

Molecular Diagnostics


High folic acid diet enhances tumour growth in PyMT-induced breast cancer

Mariann Fagernæs Hansen, Sarah Østrup Jensen, Ernst-Martin Füchtbauer and Pia M Martensen

Br J Cancer 2017 116: 752-761; advance online publication, February 2, 2017; 10.1038/bjc.2017.11

Abstract | Full Text

Blood-based microRNAs as biomarkers for the diagnosis of colorectal cancer: a systematic review and meta-analysis

Jane V Carter, Norman J Galbraith, Dongyan Yang, James F Burton, Samuel P Walker and Susan Galandiuk

Br J Cancer 2017 116: 762-774; advance online publication, February 2, 2017; 10.1038/bjc.2017.12

Abstract | Full Text

Asporin is a stromally expressed marker associated with prostate cancer progression

Annie Rochette, Nadia Boufaied, Eleonora Scarlata, Lucie Hamel, Fadi Brimo, Hayley C Whitaker, Antonio Ramos-Montoya, David E Neal, Alice Dragomir, Armen Aprikian, Simone Chevalier and Axel A Thomson

Br J Cancer 2017 116: 775-784; advance online publication, February 2, 2017; 10.1038/bjc.2017.15

Abstract | Full Text

Cancer treatment scheduling and dynamic heterogeneity in social dilemmas of tumour acidity and vasculature

Artem Kaznatcheev, Robert Vander Velde, Jacob G Scott and David Basanta

Br J Cancer 2017 116: 785-792; advance online publication, February 9, 2017; 10.1038/bjc.2017.5

Abstract | Full Text

Genetics & Genomics


Oxidative DNA damage induces hypomethylation in a compromised base excision repair colorectal tumourigenesis

Daniela Furlan, Davide Trapani, Enrico Berrino, Carla Debernardi, Mara Panero, Laura Libera, Nora Sahnane, Cristina Riva, Maria Grazia Tibiletti, Fausto Sessa, Anna Sapino and Tiziana Venesio

Br J Cancer 2017 116: 793-801; advance online publication, January 31, 2017; 10.1038/bjc.2017.9

Abstract | Full Text

Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients

Umberto Malapelle, Clara Mayo de-Las-Casas, Danilo Rocco, Monica Garzon, Pasquale Pisapia, Nuria Jordana-Ariza, Maria Russo, Roberta Sgariglia, Caterina De Luca, Francesco Pepe, Alejandro Martinez-Bueno, Daniela Morales-Espinosa, María González-Cao, Niki Karachaliou, Santiago Viteri Ramirez, Claudio Bellevicine, Miguel Angel Molina-Vila, Rafael Rosell and Giancarlo Troncone

Br J Cancer 2017 116: 802-810; advance online publication, February 7, 2017; 10.1038/bjc.2017.8

Abstract | Full Text



Mediterranean diet and risk of pancreatic cancer in the European Prospective Investigation into Cancer and Nutrition cohort

Esther Molina-Montes, María-José Sánchez, Genevieve Buckland, H B(as) Bueno-de-Mesquita, Elisabete Weiderpass, Pilar Amiano, Petra A Wark, Tilman Kühn, Verena Katzke, José María Huerta, Eva Ardanaz, José Ramón Quirós, Aurélie Affret, Mathilde His, Marie-Christine Boutron-Ruault, Petra H Peeters, Weimin Ye, Malin Sund, Heiner Boeing, Khalid Iqbal, Bodil Ohlsson, Emily Sonestedt, Anne Tjønneland, Kristina EN Petersen, Ruth C Travis, Guri Skeie, Claudia Agnoli, Salvatore Panico, Domenico Palli, Rosario Tumino, Carlotta Sacerdote, Heinz Freisling, Inge Huybrechts, Kim Overvad, Antonia Trichopoulou, Christina Bamia, Effie Vasilopoulou, Nick Wareham, Kay-Tee Khaw, Amanda J Cross, Heather A Ward, Elio Riboli and Eric J Duell

Br J Cancer 2017 116: 811-820; advance online publication, February 7, 2017; 10.1038/bjc.2017.14

Abstract | Full Text

Imaging tests in staging and surveillance of non-metastatic breast cancer: changes in routine clinical practice and cost implications

S De Placido, C De Angelis, M Giuliano, C Pizzi, R Ruocco, V Perrone, D Bruzzese, G Tommasielli, M De Laurentiis, S Cammarota, G Arpino and G Arpino

Br J Cancer 2017 116: 821-827; advance online publication, February 7, 2017; 10.1038/bjc.2017.24

Abstract | Full Text

Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999–2011

Stephen Morrell, Richard Taylor, David Roder, Bridget Robson, Marli Gregory and Kirsty Craig

Br J Cancer 2017 116: 828-839; advance online publication, February 9, 2017; 10.1038/bjc.2017.6

Abstract | Full Text



Risk of venous thromboembolism in people with lung cancer: a cohort study using linked UK healthcare data

Alex J Walker, David R Baldwin, Tim R Card, Helen A Powell, Richard B Hubbard and Matthew J Grainge

Br J Cancer 2017 116: e1; advance online publication, November 1, 2016; 10.1038/bjc.2016.364

Full Text

High-temperature-required protein A2 as a predictive marker for response to chemotherapy and prognosis in patients with high-grade serous ovarian cancers

M Miyamoto, M Takano, K Iwaya, N Shinomiya, T Goto, M Kato, A Suzuki, T Aoyama, J Hitrata, I Nagaoka, H Tsuda and K Furuya

Br J Cancer 2017 116: e2; advance online publication, November 10, 2016; 10.1038/bjc.2016.371

Full Text

Galectin-1 has potential prognostic significance and is implicated in clear cell renal cell carcinoma progression through the HIF/mTOR signaling axis

N M A White, O Masui, D Newsted, A Scorilas, A D Romaschin, G A Bjarnason, K W M Siu and G M Yousef

Br J Cancer 2017 116: e3; advance online publication, January 12, 2017; 10.1038/bjc.2016.441

Full Text

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your account at: (You will need to log in to be recognised as a registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group

No comments: